Kerry Paul is the CEO of Manuka Health New Zealand. With a strong focus on adding value to New Zealand natural health products, Manuka Health has been working with IRL on the technology transfer of a new innovation, CycloPower™. We asked Kerry to tell us more.
New titanium metal alloy open-pore materials (seen below at various magnifications) currently being developed at IRL could offer high-value contributions to the biomedical sector.
IRL Principal Scientists, Drs Gary Evans and Jeff Tallon were recognised by the Royal Society of New Zealand at its annual awards evening last night to celebrate this country’s top researchers.
IRL's Dr Geoff willmott, who has played and refereed rugby for 25 years, explores the interplay between his two passions – physics and our national sport.
IRL’s engineering brainpower is helping to fuel a drive to continue New Zealand’s legacy of innovation with a challenge to the world land speed record.
An innovative wave power[?] generator, improved carbon capture technology and a green-energy ‘pod’ for remote communities – these are just some of the R&D initiatives that demonstrate IRL’s significant research focus on new science and technology solutions offering industry the opportunity to develop low-carbon products and services.
IRL is collaborating to develop new medical technology to ensure the precise delivery of powerful new radiation therapies being adopted by Wellington Regional Hospital.
The international profile of New Zealand’s emerging high temperature superconductivity (HTS[?]) industry gained a boost recently when IRL and some of its commercialisation partners showcased HTS capabilities at several high-profile events in Europe.
Uncovering the secrets of R&D
Capital connection
Medicinal milk
Feeding industry’s needs
